Biotech ETFs Rally as Pence Promises a Orderly Transitiona Away from Obamacare


Biotechnology stocks and sector-related exchange traded funds surged Wednesday as Vice President-elect Mike Pence stated that President-elect Donald Trump's "first order of business" was to repeal the Affordable Care Act and smoothly transition to a "market-based" system.



from Biotech News